Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liqun Ren

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Journal of Ginseng Research|January 16, 2023
Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathwaysYang Zhang, Jiulong Ma, Shan Liu, et al.
Frontiers in Neuroscience|November 21, 2025
The multi-pathway treatment of flavonoids as natural compounds in neurological diseases: achievements, limitations, and prospectsYuzhu Fan, Xiaotong Lian, Xudong Ren, et al.
The Journal of Pharmacy and Pharmacology|April 6, 2021
Essential role of protein kinase C βI in icariin-mediated protection against atherosclerosisYibing Zhang, Dongsheng Xu, Peng Huang, et al.
Inflammation|August 27, 2015
Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling PathwayYanwu Hu, Bo Sun, Kai Liu, et al.
Open Medicine (Warsaw, Poland)|April 19, 2021
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillationYaowu Liu, Didi Zhu, Yunyun Xiao, et al.
Clinical and Experimental Pharmacology & Physiology|September 3, 2024
Adenylate cyclase 1 knockdown attenuates pirarubicin-induced cardiotoxicityWenqing Zhang, Zhiyun Shu, Peng Huang, et al.
Frontiers in Medicine|December 3, 2025
Flavonoids: a natural remedy in the prevention and management of diverse diseasesBo Yu, Jin Zhang, Mengxuan Zhu, et al.
Iscience|May 6, 2024
Erratum: CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axisFan Zhang, Dexian Wei, Shishun Xie, et al.
The Journal of Pharmacy and Pharmacology|October 17, 2023
Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathwayPeng Huang, Yibing Zhang, Fengjun Wang, et al.
Breast Cancer (Tokyo, Japan)|January 9, 2023
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancerJiulong Ma, Fengjun Wang, Chen Chen, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Journal of Ginseng Research|January 16, 2023
Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathwaysYang Zhang, Jiulong Ma, Shan Liu, et al.
Frontiers in Neuroscience|November 21, 2025
The multi-pathway treatment of flavonoids as natural compounds in neurological diseases: achievements, limitations, and prospectsYuzhu Fan, Xiaotong Lian, Xudong Ren, et al.
The Journal of Pharmacy and Pharmacology|April 6, 2021
Essential role of protein kinase C βI in icariin-mediated protection against atherosclerosisYibing Zhang, Dongsheng Xu, Peng Huang, et al.
Inflammation|August 27, 2015
Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling PathwayYanwu Hu, Bo Sun, Kai Liu, et al.
Open Medicine (Warsaw, Poland)|April 19, 2021
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillationYaowu Liu, Didi Zhu, Yunyun Xiao, et al.
Clinical and Experimental Pharmacology & Physiology|September 3, 2024
Adenylate cyclase 1 knockdown attenuates pirarubicin-induced cardiotoxicityWenqing Zhang, Zhiyun Shu, Peng Huang, et al.
Frontiers in Medicine|December 3, 2025
Flavonoids: a natural remedy in the prevention and management of diverse diseasesBo Yu, Jin Zhang, Mengxuan Zhu, et al.
Iscience|May 6, 2024
Erratum: CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axisFan Zhang, Dexian Wei, Shishun Xie, et al.
The Journal of Pharmacy and Pharmacology|October 17, 2023
Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathwayPeng Huang, Yibing Zhang, Fengjun Wang, et al.
Breast Cancer (Tokyo, Japan)|January 9, 2023
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancerJiulong Ma, Fengjun Wang, Chen Chen, et al.
Pageof 10